1. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646-56.
2. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the initial evaluation of the adult patient with acute musculoskeletal symptoms. Arthritis Rheum. 1996 Jan;39(1):1-8.
3. Legorreta AP, Metz RD, Nelson CF, Ray S, Chernicoff HO, Dinubile NA. Comparative analysis of individuals with and without chiropractic coverage: patient characteristics, utilization, and costs. Arch Intern Med. 2004;164:1985-92.
4. Bloomgarden ZT. Type 2 diabetes in the young: the evolving epidemic. Diabetes Care. 2004;27:998-1010.
5. Rizvi AA. Type 2 diabetes: epidemiologic trends, evolving pathogenic concepts, and recent changes in therapeutic approach. South Med J. 2004;97(11):1079-87.
6. Nelson R. US infant mortality shows first rise in 40 years. Lancet. 2004;363(9409):626.
7. Zack MM, Moriarty DG, Stroup DF, Ford ES, Mokdad AH. Worsening trends in adult health-related quality of life and self-rated health-United States, 1993-2001. Public Health Rep. 2004;119:493-505.
8. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003;95(17):1276-99.
9. US health care: a state lottery? Lancet. 2004 Nov 20;364(9448):1829-30.
10. Legorreta AP, Metz RD, Nelson CF, Ray S, Chernicoff HO, Dinubile NA. Comparative analysis of individuals with and without chiropractic coverage: patient characteristics, utilization, and costs. Arch Intern Med. 2004;164:1985-92.
11. Orme-Johnson DW, Herron RE. An innovative approach to reducing medical care utilization and expenditures. Am J Manag Care. 1997 Jan;3(1):135-44.
12. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med. 1998;105(1B):31S-38S.
13. Topol EJ. Failing the public health--rofecoxib, Merck, and the FDA. N Engl J Med. 2004 Oct 21;351(17):1707-9.
14. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA 2001; 286(8):954-9.
15. Ray WA, Griffin MR, Stein CM. Cardiovascular toxicity of valdecoxib. N Engl J Med. 2004;351(26):2767.
16. "Patients in the clinical trial taking 400 mg. of Celebrex twice daily had a 3.4 times greater risk of CV events compared to placebo. For patients in the trial taking 200 mg. of Celebrex twice daily, the risk was 2.5 times greater. The average duration of treatment in the trial was 33 months." [http://www.fda.gov/bbs/topics/news/2004/NEW01144.html]FDA Statement on the Halting of a Clinical Trial of the Cox-2 Inhibitor Celebrex Available January 4, 2005
17. "Preliminary information from the study showed some evidence of increased risk of cardiovascular events, when compared to placebo, to patients taking naproxen." [http://www.fda.gov/bbs/topics/news/2004/NEW01148.html]FDA Statement on Naproxen Available January 4, 2005.
18. [http://www.bizjournals.com/stlouis/stories/1999/07/19/daily5.html]Monsanto, Pfizer celebrate Celebrex. St. Louis Business Journal. July 20, 1999 Accessed January 5, 2005.
19. Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. JAMA. 2001 Aug 22-29;286(8):954-9.
20 Markowitz GS, Falkowitz DC, Isom R, Zaki M, Imaizumi S, Appel GB, D'Agati VD. Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. Clin Nephrol. 2003;59(2):137-42.
21. Grieco A, Miele L, Giorgi A, Civello IM, Gasbarrini G. Acute cholestatic hepatitis associated with celecoxib. Ann Pharmacother. 2002;36(12):1887-9.
22. Berger P, Dwyer D, Corallo CE. Toxic epidermal necrolysis after celecoxib therapy. Pharmacotherapy. 2002 Sep;22(9):1193-5.
23. Friedman B, Orlet HK, Still JM, Law E. Toxic epidermal necrolysis due to administration of celecoxib (Celebrex). South Med J. 2002;95(10):1213-4.
24. Lenzer J. Pfizer criticised over delay in admitting drug's problems. BMJ. 2004;329(7472):935.
25. Ray WA, Griffin MR, Stein CM. Cardiovascular toxicity of valdecoxib. N Engl J Med. 2004;351(26):2767.
26. Joy EA, Hala SV. Musculoskeletal Curricula in Medical Education: Filling In the Missing Pieces. The Physician and Sportsmedicine. 2004; 32: 42-45.
27. Joy EA, Hala SV. Musculoskeletal Curricula in Medical Education: Filling In the Missing Pieces. The Physician and Sportsmedicine. 2004; 32: 42-45.
28. Freedman KB, Bernstein J. The adequacy of medical school education in musculoskeletal medicine. J Bone Joint Surg Am. 1998;80(10):1421-7.
29. Freedman KB, Bernstein J. Educational deficiencies in musculoskeletal medicine. J Bone Joint Surg Am. 2002;84-A(4):604-8.
30. Matzkin E, Smith ME, Freccero CD, Richardson AB. Adequacy of education in musculoskeletal medicine. J Bone Joint Surg Am. 2005 Feb;87-A(2):310-4.
31. Gina Kolata. A Knee Surgery for Arthritis Is Called Sham. The New York Times, July 11, 2002.
32. Moseley JB, O'Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall DH, Hollingsworth JC, Ashton CM, Wray NP. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347:81-8.
33. Bernstein J, Quach T. A perspective on the study of Moseley et al: questioning the value of arthroscopic knee surgery for osteoarthritis. Cleve Clin J Med. 2003;70(5):401, 405-6, 408-10.
34. Manga P, Angus D, Papadopoulos C, et al. The Effectiveness and Cost-Effectiveness of Chiropractic Management of Low-Back Pain. Richmond Hill, Ontario: Kenilworth Publishing; 1993.
35. Meade TW, Dyer S, Browne W, Townsend J, Frank AO. Low-back pain of mechanical origin: randomised comparison of chiropractic and hospital outpatient treatment. BMJ. 1990;300(6737):1431-7.
36. Meade TW, Dyer S, Browne W, Frank AO. Randomised comparison of chiropractic and hospital outpatient management for low-back pain: results from extended follow up. BMJ. 1995;311(7001):349-5.
37. Legorreta AP, Metz RD, Nelson CF, Ray S, Chernicoff HO, Dinubile NA. Comparative analysis of individuals with and without chiropractic coverage: patient characteristics, utilization, and costs. Arch Intern Med. 2004;164:1985-92.
38. [http://factfinder.census.gov/home/saff/main.html?_lang=en]U.S. Census Bureau Accessed January 12, 2005.
39. Rosner AL. Evidence-based clinical guidelines for the management of acute low-back pain: response to the guidelines prepared for the Australian Medical Health and Research Council. J Manipulative Physiol Ther. 2001;24(3):214-20.
40. Topol EJ. Failing the public health-rofecoxib, Merck, and the FDA. N Engl J Med. 2004 Oct 21;351(17):1707-9.
41. Dabbs V, Lauretti WJ. A risk assessment of cervical manipulation vs. NSAIDs for the treatment of neck pain. J Manipulative Physiol Ther. 1995;18:530-6.
42. Rosner AL. Evidence-based clinical guidelines for the management of acute low-back pain: response to the guidelines prepared for the Australian Medical Health and Research Council. J Manipulative Physiol Ther. 2001;24(3):214-20.
43. Oliphant D. Safety of spinal manipulation in the treatment of lumbar disk herniations: a systematic review and risk assessment. J Manipulative Physiol Ther. 2004;27:197-210.
44. Maigne JY, Vautravers P. Mechanism of action of spinal manipulative therapy. Joint Bone Spine. 2003;70(5):336-41.
45 Brennan PC, Triano JJ, McGregor M, Kokjohn K, Hondras MA, Brennan DC. Enhanced neutrophil respiratory burst as a biological marker for manipulation forces: duration of the effect and association with substance P and tumor necrosis factor. J Manipulative Physiol Ther. 1992 Feb;15(2):83-9.
46. Brennan PC, Kokjohn K, Kaltinger CJ, Lohr GE, Glendening C, Hondras MA, McGregor M, Triano JJ. Enhanced phagocytic cell respiratory burst induced by spinal manipulation: potential role of substance P. J Manipulative Physiol Ther. 1991 Sep;14(7):399-408.
47. Heikkila H, Johansson M, Wenngren BI. Effects of acupuncture, cervical manipulation and NSAID therapy on dizziness and impaired head repositioning of suspected cervical origin: a pilot study. Man Ther. 2000 Aug;5(3):151-7.
48. Rogers RG. The effects of spinal manipulation on cervical kinesthesia in patients with chronic neck pain: a pilot study. J Manipulative Physiol Ther. 1997;20(2):80-5.
49. Bergman, Peterson, Lawrence. Chiropractic Technique. New York: Churchill Livingstone 1993. (An updated edition is now available published by Mosby.)
50. Herzog WH. Mechanical and physiological responses to spinal manipulative treatments. JNMS: J Neuromusculoskeltal System 1995; 3: 1-9.
51. Leach RA. (ed). The Chiropractic Theories: A Textbook of Scientific Research, Fourth Edition. Baltimore: Lippincott, Williams & Wilkins, 2004.
52. Dabbs V, Lauretti WJ. A risk assessment of cervical manipulation vs. NSAIDs for the treatment of neck pain. J Manipulative Physiol Ther. 1995;18:530-6.
53. Rosner AL. Evidence-based clinical guidelines for the management of acute low-back pain: response to the guidelines prepared for the Australian Medical Health and Research Council. J Manipulative Physiol Ther. 2001 Mar-Apr;24(3):214-20.
54. Oliphant D. Safety of spinal manipulation in the treatment of lumbar disk herniations: a systematic review and risk assessment. J Manipulative Physiol Ther. 2004;27:197-210.
55. Meade TW, Dyer S, Browne W, Townsend J, Frank AO. Low-back pain of mechanical origin: randomised comparison of chiropractic and hospital outpatient treatment. BMJ. 1990;300(6737):1431-7.
56. Meade TW, Dyer S, Browne W, Frank AO. Randomised comparison of chiropractic and hospital outpatient management for low-back pain: results from extended follow up. BMJ. 1995;311(7001):349-5.
57. Manga P, Angus D, Papadopoulos C, et al. The Effectiveness and Cost-Effectiveness of Chiropractic Management of Low-Back Pain. Richmond Hill, Ontario: Kenilworth Publishing; 1993.
58. Legorreta AP, Metz RD, Nelson CF, Ray S, Chernicoff HO, Dinubile NA. Comparative analysis of individuals with and without chiropractic coverage: patient characteristics, utilization, and costs. Arch Intern Med. 2004;164:1985-92.
59. Lewit K, Simons DG. Myofascial pain: relief by post-isometric relaxation. Arch Phys Med Rehabil. 1984;65(8):452-6.
60. Ingber RS. Iliopsoas myofascial dysfunction: a treatable cause of "failed" low-back syndrome. Arch Phys Med Rehabil. 1989 May;70(5):382-6.
61. Nielson NH, Bronfort G, Bendix T, Madsen F, Wecke B. Chronic asthma and chiropractic spinal manipulation: a randomized clinical trial. Clin Exp Allergy 1995;25:80-8.
62. Mein EA, Greenman PE, McMillin DL, Richards DG, Nelson CD. Manual medicine diversity: research pitfalls and the emerging medical paradigm. J Am Osteopath Assoc. 2001 Aug;101(8):441-4.
63. "There were small increases (7 to 12 liters per minute) in peak expiratory flow in the morning and the evening in both treatment groups, ... Symptoms of asthma and use of beta-agonists decreased and the quality of life increased in both groups, with no significant differences between the groups." Balon J, Aker PD, Crowther ER, Danielson C, Cox PG, O'Shaughnessy D, Walker C, Goldsmith CH, Duku E, Sears MR. A comparison of active and simulated chiropractic manipulation as adjunctive treatment for childhood asthma. N Engl J Med. 1998 Oct 8;339(15):1013-20.
64. Bronfort G, Evans RL, Kubic P, Filkin P. Chronic pediatric asthma and chiropractic spinal manipulation: a prospective clinical series and randomized clinical pilot study. J Manipulative Physiol Ther. 2001 Jul-Aug;24(6):369-77.
65. Stephens D, Pollard H, Bilton D, Thomson P, Gorman F. Bilateral simultaneous optic nerve dysfunction after periorbital trauma: recovery of vision in association with chiropractic spinal manipulation therapy. J Manipulative Physiol Ther. 1999 Nov-Dec;22(9):615-21.
66. Stephens D, Gorman F, Bilton D. The step phenomenon in the recovery of vision with spinal manipulation: a report on two 13-yr-olds treated together. J Manipulative Physiol Ther. 1997 Nov-Dec;20(9):628-33.
67. Stephens D, Gorman F. The association between visual incompetence and spinal derangement: an instructive case history. J Manipulative Physiol Ther. 1997 Jun;20(5):343-50.
68. Stephens D, Gorman RF. Does 'normal' vision improve with spinal manipulation? J Manipulative Physiol Ther. 1996 Jul-Aug;19(6):415-8.
69. Gorman RF. Monocular scotomata and spinal manipulation: the step phenomenon. J Manipulative Physiol Ther. 1996 Jun;19(5):344-9.
70. Gorman RF. Monocular visual loss after closed head trauma: immediate resolution associated with spinal manipulation. J Manipulative Physiol Ther. 1995 Jun;18(5):308-14.
71. Gorman RF. The treatment of presumptive optic nerve ischemia by spinal manipulation. J Manipulative Physiol Ther. 1995;18(3):172-7.
72. Gorman RF. Automated static perimetry in chiropractic. J Manipulative Physiol Ther. 1993 Sep;16(7):481-7.
73. Elster EL.Treatment of bipolar, seizure, and sleep disorders and migraine headaches utilizing a chiropractic technique. J Manipulative Physiol Ther. 2004 Mar-Apr;27(3):E5.
74. Alcantara J, Heschong R, Plaugher G, Alcantara J. Chiropractic management of a patient with subluxations, low-back pain and epileptic seizures. J Manipulative Physiol Ther. 1998;21(6):410-8.
75. Giesen JM, Center DB, Leach RA. An evaluation of chiropractic manipulation as a treatment of hyperactivity in children. J Manipulative Physiol Ther. 1989 Oct;12(5):353-63.
76. Bastecki AV, Harrison DE, Haas JW. Cervical kyphosis is a possible link to attention-deficit/hyperactivity disorder. J Manipulative Physiol Ther. 2004 Oct;27(8):e14.
77. Elster EL. Upper cervical chiropractic management of a patient with Parkinson's disease: a case report. J Manipulative Physiol Ther. 2000 Oct;23(8):573-7.
78. Diego MA, Field T, Hernandez-Reif M, Shaw JA, Rothe EM, Castellanos D, Mesner L. Aggressive adolescents benefit from massage therapy. Adolescence 2002 Fall;37(147):597-607.
79. Mainous RO. Infant massage as a component of developmental care: past, present, and future. Holist Nurs Pract 2002 Oct;16(5):1-7.
80. Hernandez-Reif M, Martinez A, Field T, Quintero O, Hart S, Burman I. Premenstrual symptoms are relieved by massage therapy. J Psychosom Obstet Gynaecol 2000 Mar;21(1):9-15.
81. "RESULTS: By the end of the study, the massage therapy group, as compared to the relaxation group, reported experiencing less pain, depression, anxiety and improved sleep. They also showed improved trunk and pain flexion performance, and their serotonin and dopamine levels were higher." Hernandez-Reif M, Field T, Krasnegor J, Theakston H. Lower back pain is reduced and range of motion increased after massage therapy. Int J Neurosci 2001;106(3-4):131-45.
82. Lerner BH. Sins of omission-cancer research without informed consent. N Engl J Med. 2004;351(7):628-30.
83. American Medical Association. [http://www.ama-assn.org/ama/pub/category/13638.html] Report 12 of the Council on Scientific Affairs (A-97) Full Text. Accessed January 16, 2005.
84. Leach RA (ed). The Chiropractic Theories: A Textbook of Scientific Research, Fourth Edition. Baltimore: Lippincott, Williams & Wilkins, 2004.
85. Haldeman S (ed). Principles and practice of chiropractic. Second Edition. Norwalk; Appleton and Lange, 1992.
86. Bergman, Peterson, Lawrence. Chiropractic Technique. New York: Churchill Livingstone 1993. An updated edition is now availabe published by Mosby.
87. Vasquez A. Integrative Orthopedics: The Art of Creating Wellness While Managing Acute and Chronic Musculoskeletal Disorders. Houston; Natural Health Consulting Corporation. (www.OptimalHealthResearch.com): 2004.
88. Lundberg GD. Severed trust: why American healthcare hasn't been fixed. Updated and revised. New York; Basic Books 2002.
